Clinical trials
Showing 1 - 6 of 6
Equity in Modifying Plaque Of WomEn with UndeRtreated Calcified Coronary Artery Disease (EMPOWER CAD)
To generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease.
An Adaptive Phase 2/3 Multicenter, Double-Blind, Placebo-Controlled, Randomized, Parallel, 3 Arm Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease with Mild to Moderate Aortic Stenosis (EVOID-AS).
To evaluate the efficacy of DA-1229 versus placebo in reducing the progression of aortic valve calcification as measured by cardiac computed tomography (CT) aortic valve calcium score (using the Agatston method and expressed in arbitrary units [AU]) over 2 years (104 weeks) of therapy in subjects with mild to moderate aortic stenosis.
A Trial Comparing the Effectiveness and Tolerability of Medications in Older Adults with Stable Angina and Multiple Chronic Conditions: LIVEBETTER
To establish the effectiveness and tolerability of standard of care anti-anginal treatment (beta-blocker and calcium channel blocker medications) in older adults with Stable Ischemic Heart Disease (SIHD) and multiple chronic conditions (MCC).
A Randomized Controlled Multicenter Clinical Trial Evaluating Intact Fish Skin Graft and Standard of Care versus Standard of Care alone in Nonhealing Venous Leg Ulcers
A Randomized Controlled Multicenter Clinical Trial Evaluating Intact Fish Skin Graft and Standard of Care versus Standard of Care alone in Nonhealing Venous Leg Ulcers
Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction
The primary objective of the study is to assess the clinical efficacy of selatogrel when self-administered upon occurrence of symptoms suggestive of an acute myocardial infarction (AMI) in subjects at risk of having a recurrent AMI.
Showing 1 - 6 of 6